Neurology
From the Journals
Restless legs syndrome occurs often in X-linked adrenoleukodystrophy
Patients with restless legs syndrome showed less brain demyelination than those without RLS.
Latest News
Abnormal growth of the amygdala in infants tied to autism
“We found that the amygdala grows too rapidly between 6 and 12 months of age, during a presymptomatic period in autism, prior to when the...
Conference Coverage
Physical fitness tied to lower risk of Alzheimer’s disease
“As people’s fitness improved, their risk of Alzheimer’s disease decreased – it was not an all-or-nothing proposition.”
Conference Coverage
Novel drug significantly reduces tics in Tourette syndrome – without side effects
Ecocipam does not lead to weight gain, anxiety, depression, or tardive dyskinesia, compared with placebo – a factor that may lead to better...
Conference Coverage
More evidence that COVID ‘brain fog’ is biologically based
Patients whose cognitive symptoms developed during the acute phase of COVID-19 had the highest levels of brain inflammation.
From the Journals
Atypical anxiety offers intervention target in Parkinson’s disease
A systematic review identified a range of anxiety symptoms related to motor and nonmotor symptoms of Parkinson’s disease.
From the Journals
Psychotropic med use tied to ‘striking’ post-COVID dementia risk
“It is possible that psychotropic medications may potentiate the neurostructural changes that have been found in the brain of those who have...
From the Journals
Neuropsychiatric outcomes similar for hospitalized COVID-19 patients and non–COVID-19 patients
Cognitive status in COVID-19 survivors was worse at 6 months compared to controls, but overall disease burdens were similar.
Conference Coverage
Aducanumab and ARIA: Does the FDA’s prescribing label put patients at risk?
“We’re kind of writing these protocols as information evolves,” said Dr. Meghan Riddle.
From the Journals
‘Pandemic brain’ not limited to patients infected with COVID-19
From the Journals
New guidance on cannabis use for treatment-resistant epilepsy
Though only one FDA-approved drug derived from cannabinoids exists for epilepsy, patients frequently have questions about other cannabis products...